Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Sales | 1,253 | 781 | 1,233 | 1,641 | 1,412 |
| Gross Profit | 1,253 | 781 | 1,233 | 1,641 | 1,412 |
| Operating Expenses | 23,678 | 25,034 | 25,307 | 26,607 | 23,259 |
| Operating Income | -22,425 | -24,253 | -24,074 | -24,966 | -21,847 |
| Interest Expense | 626 | 637 | 729 | 727 | 786 |
| Other Income | 52 | -2,649 | -390 | -377 | -137 |
| Pre-tax Income | -22,999 | -27,539 | -25,193 | -26,070 | -22,770 |
| Income Tax | N/A | -26 | N/A | N/A | N/A |
| Net Income Continuous | -22,999 | -27,513 | -25,193 | -26,070 | -22,770 |
| Net Income | $-22,999 | $-27,513 | $-25,193 | $-26,070 | $-32,542 |
| EPS Basic Total Ops | -0.42 | -0.56 | -0.49 | -0.91 | -0.84 |
| EPS Basic Continuous Ops | -0.33 | -0.57 | -0.52 | -0.92 | -0.89 |
| EPS Diluted Total Ops | -0.42 | -0.56 | -0.49 | -0.91 | -0.84 |
| EPS Diluted Continuous Ops | -0.33 | -0.57 | -0.52 | -0.92 | -0.89 |
| EBITDA(a) | $-21,113 | $-20,316 | $-22,030 | $-22,908 | $-19,913 |